logo
logo

Circulogene Theranostics announced it raised $750,000 in an initial filing from an offering of $3.25 Million

Aug 18, 2022about 3 years ago

Amount Raised

$750,000

Round Type

seed

BirminghamHealthcare

Company Information

Company

CirculoGene Theranostics, LLC

Location

3125 Independence Drive

Birmingham, Alabama, United States

About

Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. One tube, one week, complete results. Somatic + Germline; Blood + Tissue + Buccal; DNA + RNA + MSI + PD-L1. CONTACT info@circulogene.com For Asia Pacific inquiries, please email AsiaPacfic@circulogene.com For Middle Eastern inquiries, please email Irem.Agin@circulogene.com.tr

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech